123
Views
0
CrossRef citations to date
0
Altmetric
Commentaries

The broader prospects for bispecifics in Hodgkin lymphoma

&
Pages 1777-1779 | Received 18 Jul 2022, Accepted 20 Jul 2022, Published online: 03 Aug 2022
 

Author contributions

K.L.C and S.M.A wrote all aspects of this manuscript.

Disclosure statement

S.M.A receives research funding from: Bristol-Myers Squibb, Seattle Genetics, Affimed Therapeutics, Regeneron, Trillium Therapeutics, AI Therapeutics, ADC Therapeutics. All remaining authors declare no competing conflict-of-interests.

Log in via your institution

Log in to Taylor & Francis Online

PDF download + Online access

  • 48 hours access to article PDF & online version
  • Article PDF can be downloaded
  • Article PDF can be printed
USD 65.00 Add to cart

Issue Purchase

  • 30 days online access to complete issue
  • Article PDFs can be downloaded
  • Article PDFs can be printed
USD 1,065.00 Add to cart

* Local tax will be added as applicable

Related Research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.